Baird lowered the firm’s price target on Dentsply Sirona (XRAY) to $20 from $22 and keeps a Neutral rating on the shares. The firm updated its model following Q4 results which showed a bit of progress but also revealing there is alot left to do.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on XRAY:
- Dentsply Sirona price target lowered to $19 from $20 at Wells Fargo
- Dentsply Sirona price target lowered to $19 from $20 at BofA
- Hold Rating for DENTSPLY SIRONA Amid Cost-Cutting and Market Challenges
- Dentsply Sirona Faces Challenges with 2024 Earnings
- Morning Movers: Nvidia and Snowflake rise following quarterly earnings releases